ABBV Dec 2025 105.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:10AM EDT. Market open.
| Previous close | 71.57 |
| Open | 71.57 |
| Bid | 60.55 |
| Ask | 62.10 |
| Strike | 105.00 |
| Expiry date | 2025-12-19 |
| Day's range | 71.57 - 71.57 |
| Contract range | N/A |
| Volume | |
| Open interest | 14 |
PR NewswireAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals today announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's innovative research platform to discover novel neuroplastogens.
GOBankingRates29 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
You may think you know all of the big, powerful, multinational companies, from Walmart to Apple to Amazon. But you might be surprised at how many companies with tens of billions in annual revenue...
ZacksIronwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Ironwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss estimates. The company lowers revenue guidance for 2024. Stock falls.
© 2024 Yahoo. All rights reserved.